Communiqués

Discours

5 février 2008 Présentation au Comité permanent de la santé de la Chambre des communes Étude sur la surveillance après la mise en marché Étude sur la surveillance après la mise en marché
April 23, 2007 Presentation by Apotex President and COO Jack Kay to the House of Commons Standing Committee on Industry, Science and Technology The Apotex Experience with Canada’s Access to Medicines Regime - ENGLISH ONLY
April 23, 2007 Presentation by CGPA President Jim Keon to the House of Commons Standing Committee on Industry, Science and Technology Review of Canadian Access to Medicines Regime - ENGLISH ONLY
June 1, 2006 Presentation by CGPA President Jim Keon to the Economic Club of Toronto Bill 102: Ontario’s Prescription for Drug Cost Savings and Greater Transparency - ENGLISH ONLY